Richard Colbeck (Tasmania, Liberal Party, Minister for Senior Australians and Aged Care Services) Share this | Hansard source

The government continues to work to support Australians in the fight against COVID-19, including with additional treatments. In recent times, we've secured access to two additional treatments. Under a new agreement with Roche Products Australia, we'll be supplied with 15,000 doses of the COVID-19 antibody based therapy Ronapreve. Ronapreve is expected to be targeted for use in unvaccinated people who are at risk of developing severe disease.

In addition, the Australian government has secured access to 500,000 treatment courses of Pfizer's COVID-19 oral antiviral drug. This treatment is still undergoing clinical trials. It is expected to help reduce the severity or onset of illness. It's expected to be available next year.

Australia has also secured an advance purchase agreement for 300,000 courses of the promising oral COVID-19 treatment for— (Time expired)